Joana Gonçalves de Gouveia Maia Xavier
Investigador doutorado
Centro de Investigação em Tecnologias e Serviços de Saúde
Subsistema
Investigadores
Unidade ID
Centro de Investigação em Tecnologias e Serviços de Saúde
Regime
Exclusividade
Vínculo
CT em Funções Públicas a termo resolutivo certo
Joana M. Xavier completed her BSc in Biology in 2004 and her MSc in Human Biology and Environment in 2006, both at Faculdade de Ciências from the Universidade de Lisboa. In 2009 she joined the PhD program from Faculdade de Medicina, Universidade de Lisboa, having completed her graduation in 2013 with distinção e louvor in the field of Biomedical Sciences - speciality of Genetics. During her Master and PhD she worked at Instituto Gulbenkian de Ciências and Instituto de Medicina Molecular in the field of Human Genetics and published 5 papers as first author (about Behçet's disease susceptibility) and another 4 papers as a co-author (on Behçet's disease, aneurysms and stroke genetic susceptibility). In 2013 Joana M. Xavier moved to University of Algarve where she first worked at the System Biology Group (CBME) where she co-authored 2 publications in the field of stem cells, molecular interactions and networks. At UAlg Joana M. Xavier kept her collaboration with her previous PhD supervisor having co-authored 2 additional publications in the field of Human Genetics (peripheral arterial disease, venous thromboembolism and ulcerative colitis susceptibility). In 2014 she joined the Functional Genomics of Breast Cancer Group in CBMR (Centre for Biomedical Research - UAlg) where she has been working ever since although, the group moved to CINTESIS - UAlg in the beginning of 2021. In 2019 Joana M. Xavier began her contract as an Assistant Investigator. The work developed in the field of breast cancer genomics under her current contract resulted in three journal articles published, another two in revision (pre-printed in biorxiv) and two European patents submitted as co-Inventor. One of these patents was on a novel prognostic molecular biomarker for breast cancer, based on which Joana M. Xavier and Ana Teresa Maia developed a business idea, expressPIK - a companion diagnostic test for breast cancer, that won the Born from Knowledge (BfK) Ideas 2021 contest. In 2022 Joana Xavier co-founded expressTEC, a spinoff from UAlg, where she is CTO, to develop companion diagnostics test for targeted cancer treatment based on RNA-technology. During her scientific career, Joana M. Xavier has participated in several funded projects and in the last 5 years has coordinated two FCT project as PI (2019-2023; 2023-ongoing) and participated in another one as team member (2018-2022). Additionally, Joana M. Xavier supervised a team of researchers and student's and gave classes to both BSc and MSc courses. Since 2021 Joana M. Xavier is also a member of the coordination committee of the Volunteering Group from the University of Algarve. Between 2016 and 2019 Joana M. Xavier took two maternity leaves.
Atividades
Atividades
2023/02/17 - 2033/02/18. Participação em evento. Participation in Women in Tech Algarve Summit as expressTEC co-founder. expressTEC won the startups pitch competition.. Simpósio. Women in Tech Algarve Summit.
2020/07/01 - 2023/06/30. Tutoria. PhD Investigator hired by INTERGEN project - Innovating breast cancer GWAS through inTEgRation of functional GENomics. Marinella Ghezzo .
2023/03/29 - 2023/03/29. Participação em evento. Participation as an exhibitor (representative of expressTEC) in TECH4INNOV: the Present and the Future of Innovation, promoted by ANI.. Exposição. TECH4INNOV: the Present and the Future of Innovation. Agência Nacional de Inovação SA.
2022/07/25 - 2023/03/27. Tutoria. MSc Researcher hired by INTERGEN project - Innovating breast cancer GWAS through inTEgRation of functional GENomics. André Duarte.
2023/03/22 - 2023/03/22. Participação em evento. Participation IN TECH Algarve - Conversation with Technology, dedicated to the topic of Knowledge Transfer, at UAlg TEC CAMPUS.. IN TECH Algarve - Conversation with Technology, dedicated to the topic of Knowledge Transfer.. UAlg Tec Campus.
2020/09/06 - 2023/03/08. Orientação. Study of the association of Allelic Expression (AE) ratios with BC clinical features .Oncobiologia - Mecanismos Moleculares do Cancro (Mestrado). Orientador de António Góis.
2022/11/09 - 2023/02/16. Participação em evento. Participation in Born from Knowledge (Bfk)-RISE (Science and Technology Acceleration Program to enhance the results of Research & Development (R&D) and existing technologies in the National Scientific and Technological System with commercialization potential, through monitoring and intensive training of teams). Concurso. Born from Knowledge (Bfk)-RISE. Agência Nacional de Inovação SA.
2023/01/23 - 2023/02/03. Orientação. Analysis of regulation of alternative transcription by candidate risk regulatory variants at breast cancer risk loci.Biologia Computacional e Bioinformática (Outra). Coorientador de Beatriz Fernandes Carrasqueiro.
2022/10/01 - 2023/02/01. Participação em evento. Participation in Go-SME project (Programme that selects the most promising early-stage innovation projects of start-ups and highly innovative SMEs with international ambitions to turn strong, innovative business ideas into winners on the market). Concurso. Go-SME project . Agência Nacional de Inovação SA.
2023/01/26. Apresentação oral de trabalho. Risco genético para cancro da mama e o papel das variantes reguladoras de expressão génica. essions “Geneticamente falando”. Portuguese Society of Genetics (SPG) (Portugal).
2023/01/20 - 2023/01/20. Participação em evento. Scientific Meeting between researchers of RISE to strength colaborations. Encontro. 1st Scientific Meeting of RISE. RISE - Rede de Investigação em Saúde; Centro de Investigação em Tecnologias e Serviços de Saúde.
2022/05/01 - 2022/06/30. Orientação. Avaliação de moduladores genéticos de splicing associados a risco de cancro da mama.Ciências Biomédicas (Licenciatura/Bacharelato). Coorientador de Sofia Viegas de Sousa.
2022/05/01 - 2022/06/30. Orientação. Análise Funcional de variantes de risco para cancro da mama associadas ao splicing alternativo.Ciências Biomédicas (Licenciatura/Bacharelato). Coorientador de Beatriz Fernandes Carrasqueiro.
2022/04/01 - 2022/05/07. Orientação. Identification and characterization of new loci involved in breast cancer risk.Mestrado Integrado em Medicina da UAlg (5-weeks laboratory internships) (Outra). Coorientador de Tomás Saraiva da Ponte.
2022/04/01 - 2022/05/07. Orientação. Identification and Characterisation of Cis-Regulatory Loci involved in Breast Cancer Risk.Mestrado Integrado em Medicina da UAlg (5-weeks laboratory internships) (Outra). Coorientador de Ana Filipa Gaudêncio Silva.
2022/05/03 - 2022/05/04. Participação em evento. Participation in an activity entitled “ET hereditariety” for middle school and high school students at the Open Day (Dia Aberto) from the University of Algarve. Exposição. Open Day (Dia Aberto) from the University of Algarve. Universidade do Algarve Departamento de Ciências Biomédicas e Medicina.
2022/05/03 - 2022/05/04. Participação em evento. Organization and participation in an activity entitled “Extraction of DNA from fruit” for middle school and high school students at the Open Day (Dia Aberto) from the University of Algarve. . Exposição. Universidade do Algarve Departamento de Ciências Biomédicas e Medicina.
2021/10/14 - 2021/10/15. Participação em evento. Attendance to the II ASPIC-ASEICA International Meeting - Current Trends in Precision Medicine in Cancer. Encontro. II ASPIC-ASEICA International Meeting – Current Trends in Precision Medicine in Cancer. Associação Portuguesa de Investigação em Cancro.
2021/10/08 - 2021/10/08. Participação em evento. Invited lecture entitled An Introduction to Breast Cancer. Simpósio. Outubro Rosa Liga Portuguesa (Breast Cancer awareness initiative). Liga Portuguesa Contra o Cancro.
2021/08/31 - 2021/08/31. Entrevista / Programa (rádio / tv). RTP dias do Futuro (Antena 1). Investigation currently developed and the BfK Ideas price achieved.
2021/08/06. Apresentação oral de trabalho. Allelic expression imbalance of PIK3CA mutations in breast cancer is frequent and prognostically significant. Worldwide PI3K Zoom seminar series. Host Lab: CellSig (Prof B. Vanhaesebroeck), UCL, Cancer Institute, London.
2021/07/08 - 2021/07/15. Participação em evento. Participation in BfK (Born from Knowledge) Ideas 2020. Development of a business idea: expressPIK - the RNA test specific to identify patients with breast cancer eligible for an innovative treatment. Team: Ana Teresa Maia and Joana Xavier. . Concurso. BfK (Born from Knowledge) Ideas Contest 2020. Agência Nacional de Inovação SA.
2021/07/12. Apresentação oral de trabalho. A capacitação para o voluntariado: a experiência do Grupo de Voluntariado UAlg” V+. 7º Congresso Nacional de Práticas Pedagógicas no Ensino Superior (CNaPPES.21). Universidade de Aveiro (Aveiro, Portugal).
2021/05/20 - 2021/05/21. Participação em evento. Attendance to the Meeting - Stemness & Metastasis: Advances in Research and Clinical Translation. Encontro. Porto Cancer Meeting - Stemness & Metastasis: Advances in Research and Clinical Translation. Universidade do Porto.
2021/05/20 - 2021/05/21. Participação em evento. Attendance of the 27th Porto Cancer Meeting - Stemness & Metastasis: Advances in Research and Clinical Translation.. Encontro. 27th Porto Cancer Meeting - Stemness & Metastasis: Advances in Research and Clinical Translation..
2021/05/18 - 2021/05/19. Participação em evento. Attendance to the Virtual Conference on Bioinformatics in Cancer. Conferência. The European Association for Cancer Research (EACR) Virtual Conference on Bioinformatics in Cancer. European Association For Cancer Research.
2021/05/18 - 2021/05/19. Participação em evento. Attendance to the European Association for Cancer Research (EACR) Virtual Conference on Bioinformatics in Cancer. Conferência. European Association for Cancer Research (EACR) Virtual Conference on Bioinformatics in Cancer. European Association For Cancer Research.
2021/05/01 - Presente. Membro de comissão. Member of the coordination committee of the UAlg V+ Group (Volunteering Group from the University of Algarve) as Faculty of Medicine and Biomedical Sciences (FMCB) representative. Membro. Universidade do Algarve.
2021/02/08 - 2021/02/10. Participação em evento. Attendance to the Genomic Regulation 2021: Focus on Cancer. Encontro. Genomic Regulation 2021: Focus on Cancer, Swiss Institute on Bioinformatics (SIB).
2021/01/26 - 2021/01/28. Participação em evento. Ensembl Browser Workshop. Oficina (workshop). Ensembl Browser Workshop. European Bioinformatics Institute.
2019/06/01 - 2020. Comissão de avaliação. Juri panel member (President) of an international tender for the recruitment of a post-doctoral associate researcher under the research project INTERGEN - INnovating breast cancer GWAS through inTEgRation of functional GENomics. Universidade do Algarve. Fundação para a Ciência e Tecnologia (FCT).
2019/09/01 - 2020. Comissão de avaliação. Juri panel member (vogal efectivo) of a research fellowship for the recruitment of a doctorate under the research project POCI-01-0145-FEDER-022184 GenomePT. Universidade do Algarve. Fundação para a Ciência e Tecnologia (FCT).
2020/10/06 - Presente. Curso / Disciplina lecionado. Oncogenética e Oncogenómica. Oncobiologia - Mecanismos Moleculares do Cancro (Mestrado). Universidade do Algarve Departamento de Ciências Biomédicas e Medicina.
2020/09/20 - 2020/09/20. Participação em evento. Attendance to Cancer Biology: From Basic To Translational Research. Simpósio. Liga Portuguesa Contra o Cancro.
2020/06/22 - 2020/06/24. Participação em evento. Attendance to the American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting II. Encontro. 2020 Virtual Annual Meeting II. American Association for Cancer Research.
2020/02/20 - 2020/02/20. Organização de evento. Organization of an activity entitled “Extraction of DNA from fruit” for middle school and high school students at the Open Day (Dia Aberto) from the University of Algarve (2020). Universidade do Algarve.
2019/12/09 - Presente. Arbitragem científica em revista. BMC Bioinformatics (1471-2105). Springer (Biomed Central Ltd.).
2019/09/29 - 2019/10/02. Participação em evento. Attendance to the EMBO | EMBL Symposium: Systems Genetics: From Genomes to Complex Traits. Simpósio. EMBO | EMBL Symposium: Systems Genetics: From Genomes to Complex Traits.
2019/07/30. Apresentação oral de trabalho. Innovating breast cancer GWAS through integration of functional Genomics.. CBMR scientific meeting. CBMR (Loulé, Portugal).
2017/09/03 - 2018/08/15. Orientação. Identifying novel genes associated with breast cancer susceptibility using differential allelic expression ratios.Oncobiologia - Mecanismos Moleculares do Cancro (Mestrado). Coorientador de Catarina Martins .
2018/01/26. Apresentação oral de trabalho. Uncovering miRNA-mediated cis-regulation in common cancers. . CIMAGO Scientific Meeting. CIMAGO (Coimbra, Portugal).
2017/11/17. Apresentação oral de trabalho. Mapping of cis-regulatory variants helps dissecting the risk mechanism for breast cancer associated 5q14.1 locus. 21ª Reunião da Sociedade Portuguesa de Genética Humana (SPGH). Sociedade Portuguesa de Genética Humana (SPGH) (Costa da Caparica, Portugal).
2017/11/17. Apresentação oral de trabalho. miRNA-mediated cis-regulation in breast cancer susceptibility. 21ª Reunião da Sociedade Portuguesa de Genetica Humana (SPGH). Sociedade Portuguesa de Genetica Humana (SPGH) (Costa da Caparica, Portugal).
2017/11/01 - Presente. Curso / Disciplina lecionado. Genética Humana. Ciências Biomédicas (Licenciatura). Universidade do Algarve Departamento de Ciências Biomédicas e Medicina.
2016/09/03 - 2017/08/15. Orientação. The role of miRNA-mediated cis-regulation in breast cancer susceptibility.Oncobiologia - Mecanismos Moleculares do Cancro (Mestrado). Coorientador de Ana Catarina Jacinta Fernandes.
2017/01/06 - 2017/02/10. Arbitragem científica em revista. Computer Methods and Programs in Biomedicine.
2015/02/01 - 2016/07/31. Orientação. Functional Characterisation of Putative Cis-Regulatory Risk Loci for Breast Cancer.EMQAL Erasmus Mundus (Mestrado). Coorientador de Noordiana Rosli.
2016/05/01 - 2016/06/30. Orientação. Estudo da influência de polimorfismos de risco para cancro da mama na regulação por miRNAs.Ciências Biomédicas (Licenciatura/Bacharelato). Coorientador de Pedro Conceição .
2015/11/29 - 2015/12/02. Participação em evento. Course on Analysis of High-throughput sequencing data with Bioconductor. Oficina (workshop). Analysis of High-throughput sequencing data with Bioconductor. University of Cambridge Centre for Applied Medical Statistics.
2015/05/01 - 2015/06/30. Orientação. Identificação de novos marcadores genéticos de risco para o cancro da mama.Bioquímica (Licenciatura/Bacharelato). Coorientador de Rita Simão.
2015/05/01 - 2015/06/30. Orientação. Identificação de novos marcadores genéticos de risco para cancro da mama.Ciências Biomédicas (Licenciatura/Bacharelato). Coorientador de Bernardo P Almeida.
2014/11/20. Apresentação oral de trabalho. Identification of 4 novel susceptibility loci for intracranial aneurysms in Portuguese using a pooling-based GWAS.. 18ª Reunião da Sociedade Portuguesa de Genetica Humana (SPGH). Sociedade Portuguesa de Genetica Humana (SPGH) (Lisboa, Portugal).
2014/05/01 - 2014/06/30. Orientação. Influência da variação genética na expressão de mutações em cancro.Ciências Biomédicas (Licenciatura/Bacharelato). Coorientador de Inês Gomes.
2013/11/22. Apresentação oral de trabalho. FUT2: filling the gap between genes and environment in Behçet’s disease? . 17th Annual Meeting of the Portuguese Society of Human Genetics. Sociedade Portuguesa de Genética Humana (SPGH) (Coimbra, Portugal).
2013/06/12. Apresentação oral de trabalho. Genome-wide association study identifies FUT2 as a novel genetic risk factor for Behçet’s disease. XXXVIII Jornadas Portuguesas de Genética.. Sociedade Portuguesa de Genetica (Porto, Portugal).
2013/04/04. Apresentação oral de trabalho. Identification of FUT2 as a risk factor for Behçet's disease in a genome-wide association study. Joint Conference of HGM and 21st International Congress of Genetics.
2012/11/11 - 2012/11/14. Participação em evento. Course on Automated and Reproducible Analysis of NGS data. Oficina (workshop). Automated and Reproducible Analysis of NGS data. Instituto Gulbenkian de Ciência.
2012/09/14 - 2012/09/16. Participação em evento. Course on Programming for Scientists. Oficina (workshop). Programming for Scientists. Instituto de Medicina Molecular João Lobo Antunes.
2012/05/28. Apresentação oral de trabalho. Gene expression and disease association analyses implicate EREG-AREG and NRG1 in susceptibility to Behçet’s Disease. XXXVII Jornadas Portuguesas de Genética.
2008/05/06. Apresentação oral de trabalho. Searching for a common genetic factor for Behçet’s disease and Ankylosing Spondylitis. . Marie Curie - Genome Architecture in Relation to Disease, Interplay among genetics, epigenetics and non-coding RNA's, .
Projetos
Projetos
2015/11/01 - 2019/05/31. Unveiling cis-regulatory variants role in breast cancer aetiology. Bolseiro de Pós-Doutoramento. Universidade do Algarve.
2018/06/01 - 2022/05/31. DEvoCancer: Decoding breast cancer evolution through mutant allele differential expression signatures, Concurso de Projetos de I&D em Todos os Domínios Científicos. Investigador. Universidade do Algarve.
2019/05/30 - 2025/05/29. Unveiling cis-regulatory variants role in breast cancer aetiology, DL 57/2016. Investigador. Universidade do Algarve.
2023/02/20 - 2024/08/19. Exploring the shared regulatory genetic basis in cancer risk, 3599-PPCDT. Investigador responsável. Universidade do Algarve.
2019/03/28 - 2023/03/27. Innovating breast cancer GWAS through inTEgRation of functional GENomics, 9471 - RIDTI. Investigador responsável. Universidade do Algarve.
2013/05 - 2015/10. Patients as Health Care Innovators: An Empirical Investigation of Treatment, Therapies and Medical Devices (TT&MD) developed by Patients of Chronic Diseases. Investigador. Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes.
2014/03/15 - 2015/10/31. Cis-regulation of somatic mutations in breast and ovarian cancers. Bolseiro de Pós-Doutoramento. Universidade do Algarve Centro de Investigação em Biomedicina.
2013/04/01 - 2013/06/30. Genetics of Nonsyndromic Cleft Lip and Palate NSCLP, 3599-PPCDT. Bolseiro de Técnico de Investigação. Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes; Fundação Calouste Gulbenkian; Hospital de São João.
2010/01/01 - 2013/04/30. BEDGET: decifrar a genética da doença de Behçet, 3599-PPCDT. Investigador. Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes; Fundação Calouste Gulbenkian.
2009/01/01 - 2012/12/31. IDENTIFICATION OF GENETIC RISK FACTORS FOR BEHÇETS DISEASE, PIDDAC. Universidade de Lisboa Faculdade de Medicina.
2008/04/01 - 2008/09/30. microRnómica e proteómica da doença de Parkinson, 3599-PPCDT. Bolseiro de Investigação. Fundação Calouste Gulbenkian; Instituto Gulbenkian de Ciência; Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes.
Produções
Xavier, Joana M. 2022. "METHODS OF ANALYSIS OF POLYMORPHISMS ASSOCIATED WITH CANCER AND USES THEREOF". Pendente.
Xavier, Joana M. 2022. "Methods of analysis of polymorphisms associated with allelic expression of PIK3CA in cancer and uses thereof". Pendente.
Esteves, Filipa; Xavier, Joana M.; Ford, Anthony M.; Rocha, Cátia; Pharoah, Paul D.P.; Caldas, Carlos; Chin, Suet-Feung; Maia, Ana-Teresa. 2022. "Germline allelic expression of genes at 17q22 locus associates with risk of breast cancer". European Journal of Cancer, 172: 146-157. https://doi.org/10.1016/j.ejca.2022.05.034
Xavier, Joana M; Magno, Ramiro; Russel, Roslin; Almeida, Bernardo P; Jacinta-Fernandes, Ana; Duarte, André; Dunning, Mark; et al. 2022. "Mapping of cis-regulatory variants by differential allelic expression analysis identifies candidate risk variants and target genes of 27 breast cancer risk loci ". medrXiv. https://www.medrxiv.org/content/10.1101/2022.03.08.22271889v1
Correia, Lizelle; Magno, Ramiro; Xavier, Joana M.; de Almeida, Bernardo P.; Duarte, Isabel; Esteves, Filipa; Ghezzo, Marinella; et al. 2022. "Allelic expression imbalance of PIK3CA mutations is frequent in breast cancer and prognostically significant". npj Breast Cancer, 8 (1). https://doi.org/10.1038/s41523-022-00435-9
Ghezzo, Marinella N; Magno, Ramiro; Xavier, Joana M; Maia, Ana-Teresa. 2022. Redesigned case-control study using allelic expression as a quantitative phenotype identifies new risk loci for breast cancer. Em 5th ASPIC International Congress.
2022. expressTEC. R&D. https://expresstec.pt
Xavier, Joana; Magno, Ramiro; Russel, Roslin; de Almeida, Bernardo P.; Jacinta-Fernandes, Ana; Duarte, André; BARBOSA-MORAIS, NUNO; Maia, Ana-Teresa. 2021. Mapping of cis-regulatory variants by differential allelic expression analysis identifies regulatory variants and target genes of 31 breast cancer risk loci. Em EACR - Bioinformatics in Cancer. Virtual Event, Worldwide.
Jacinta-Fernandes, Ana; Xavier, Joana M.; Magno, Ramiro; Lage, Joel G.; Maia, Ana-Teresa. 2020. "Allele-specific miRNA-binding analysis identifies candidate target genes for breast cancer risk". npj Genomic Medicine, 5 (1). https://doi.org/10.1038/s41525-019-0112-9
Magno, Ramiro; Martel, Paulo; Ghezzo, Marinella; Xavier, Joana M; Maia, Ana-Teresa. 2020. Exploring the role of alternative splicing in breast cancer risk.. Em Cancer Biology: From Basic To Translational Research. .
Juliana Machado; Ramiro Magno; Joana M Xavier; Ana-Teresa Maia. 2019. Alternative splicing regulation by GWAS risk loci for breast cancer. https://doi.org/10.1101/766394
Xavier, Joana M; Magno, Ramiro; Rocha, Cátia L; Dunning, M; Russell, Roslin; Maia, Ana-Teresa. 2019. Mapping cis-regulatory variants pinpoints target genes of breast cancer risk loci. Em EMBO | EMBL Symposium: Systems Genetics: From Genomes to Complex Traits..
Esteves, Filipa; Xavier, Joana M; Maia, Ana-Teresa. 2019. DAE identifies COX11 and TOM1L1 as target genes in breast cancer risk locus 17q22. Em EMBL Conference: Cancer Genomics.
Matias, A.T.; Jacinta-Fernandes, A.; Magno, R.; Xavier, J.; Cabral, M.G.; Jacinto, A.; Maia, A.T.; Braga, S.. 2018. "Differential molecular signature in patients from African origin with triple-negative breast cancer". Em Annals of oncology : official journal of the European Society for Medical Oncology, viii95-viii95. https://doi.org/10.1093/annonc/mdy272.290
Xavier, Joana M; Magno, Ramiro; Almeida, Bernardo P.; Maia, Ana-Teresa. 2018. Integrative genomic approach elucidates the risk mechanism for breast cancer associated 5q14.1 locus. Em 3rd ASPIC International Congress.
Martins, Catarina; Xavier, Joana; Magno, Ramiro; Maia, Ana-Teresa. 2018. Identifying novel genes associated with Breast Cancer susceptibility using Allelic Expression Ratios. Em 3rd ASPIC International Congress.
Machado, J; Magno, R; Xavier, JM; Maia, AT. 2018. Uncovering the role of alternative splicing in Breast Cancer susceptibility. Em EMBL conference - Transcription and Chromatin.
Esteves, Filipa; Magno, Ramiro; Xavier, Joana M (EE13-176A-5613); Maia, Ana-Teresa. 2018. A comprehensive analysis of RNA-Seq data to identify risk variants for breast cancer using allelic expression. Em EMBL Conference: From Functional Genomics to Systems Biology.
Esteves, Filipa; Magno, Ramiro; Xavier, Joana M (EE13-176A-5613); Maia, Ana-Teresa. 2018. Identification of risk variants for breast cancer: a comprehensive analysis of RNA-Seq data. Em 3rd ASPIC International Congress.
Jacinta-Fernandes, A; Xavier, Joana M; Magno, Ramiro; Jerónimo, Carmen; Maia, Ana-Teresa. 2018. Revealing the role of allele- specific miRNA regulation in prostate cancer susceptibility. Em 3rd ASPIC International Congress..
Matias, A.T.; Jacinta-Fernandes, A.; Magno, R.; Xavier, J.; Cabral, M.G.; Jacinto, A.; Maia, A.T.; Braga, S.. 2018. "Differential molecular signature in patients from African origin with triple-negative breast cancer". Annals of Oncology, 29. https://doi.org/10.1093/annonc/mdy272.290
Abrantes, Patrícia; Rosa, Alexandra; Francisco, Vânia; Sousa, Inês; Xavier, Joana M.; Oliveira, Sofia A.. 2016. "Mitochondrial genome association study with peripheral arterial disease and venous thromboembolism". Atherosclerosis, 252: 97-105. https://doi.org/10.1016/j.atherosclerosis.2016.07.920
Xavier, J.; Almeida, B.; Sun, C.; Silva, J.; Marreiros, A.; Eldridge, M.; Bernards, R.; et al. 2016. "PIK3CA mutant allele differential expression (MADE) associates with breast cancer clinical features". Trabalho apresentado em EACR24: From basic research to precision medicine, Manchester, Reino Unido, 61. https://doi.org/10.1016/s0959-8049(16)61723-9
Rosa, A.; Abrantes, P.; Sousa, I.; Francisco, V.; Santos, P.; Francisco, D.; Xavier, J.M.; Oliveira, S.A.. 2016. "Ulcerative colitis is under dual (Mitochondrial and Nuclear) genetic control". Inflammatory Bowel Diseases, 22 (4): 774-781. https://doi.org/10.1097/MIB.0000000000000694
Abrantes, Patrícia; Santos, Maria M.; Sousa, Inês; Xavier, Joana M.; Francisco, Vânia; Krug, Tiago; Sobral, João; et al. 2015. "Genetic Variants Underlying Risk of Intracranial Aneurysms: Insights from a GWAS in Portugal". PLOS ONE, 10 (7). https://doi.org/10.1371/journal.pone.0133422
Xavier, Joana; Russell, Roslin; Almeida, Bernardo P.; Rosli, Nordiana; Rocha, Catia; Samarajiwa, Shamith; Chin, Suet-Feung; et al. 2015. "Integrative differential allelic expression analysis efficiently reveals the biology underlying risk to breast cancer". Em Mol Cancer Res, vol 61, Suppl 1 . https://doi.org/10.1158/1557-3125.advbc15-a31
Sousa, Inês; Shahram, Farhad; Francisco, David; Davatchi, Fereydoun; Abdollahi, Bahar Sadeghi; Ghaderibarmi, Fahmida; Nadji, Abdolhadi; et al. 2015. "Brief Report: Association ofCCR1,KLRC4,IL12A-AS1,STAT4, andERAP1With Behçet's Disease in Iranians". Arthritis & Rheumatology, 67 (10): 2742-2748. https://doi.org/10.1002/art.39240
Xavier, Joana M; Davatchi, Fereydoun; Abade, Olga; Shahram, Farhad; Francisco, Vânia; Abdollahi, Bahar Sadeghi; Trindade, Hélder; et al. 2015. "Characterization of the major histocompatibility complex locus association with Behçet’s disease in Iran". Arthritis Research & Therapy, 17 (1). https://doi.org/10.1186/s13075-015-0585-6
Xavier, J.M.; Shahram, F.; Sousa, I.; Davatchi, F.; Matos, M.; Abdollahi, B.S.; Sobral, J.; et al. 2015. "FUT2: Filling the gap between genes and environment in Behçet's disease?". Annals of the Rheumatic Diseases, 74 (3): 618-624. https://doi.org/10.1136/annrheumdis-2013-204475
Machado, Rui S. R.; Xavier, Joana M.; Futschik, Matthias E.. 2014. "Targeting molecular networks for drug research". Frontiers in Genetics, 5. https://doi.org/10.3389/fgene.2014.00160
Pinto, José P.; Reddy Kalathur, Ravi Kiran; Machado, Rui S. R.; Xavier, Joana M.; Bragança, José; Futschik, Matthias E.. 2014. "StemCellNet: an interactive platform for network-oriented investigations in stem cell biology". Nucleic Acids Research, 42 (W1): W154-W160. https://doi.org/10.1093/nar/gku455
Matos, Mafalda; Xavier, Joana M.; Abrantes, Patrícia; Sousa, Inês; Rei, Nádia; Davatchi, Fereydoun; Shahram, Farhad; et al. 2014. "IL10
low-frequency variants in Behçet's disease patients". International Journal of Rheumatic Diseases, 20 (5): 622-627. https://doi.org/10.1111/1756-185x.12369
low-frequency variants in Behçet's disease patients". International Journal of Rheumatic Diseases, 20 (5): 622-627. https://doi.org/10.1111/1756-185x.12369
Xavier, Joana Gonçalves de Gouveia Maia, 1984-. 2013. "Identification of genetic risk factors for Behçet’s disease". Doutoramento. http://hdl.handle.net/10451/10517
Xavier, J.M.; Krug, T.; Davatchi, F.; Shahram, F.; Fonseca, B.V.; Jesus, G.; Barcelos, F.; et al. 2013. "Gene expression profiling and association studies implicate the neuregulin signaling pathway in Behçet's disease susceptibility". Journal of Molecular Medicine, 91 (8): 1013-1023. https://doi.org/10.1007/s00109-013-1022-4
Xavier, Joana M.; Shahram, Farhad; Davatchi, Fereydoun; Rosa, Alexandra; Crespo, Jorge; Abdollahi, Bahar Sadeghi; Nadji, Abdolhadi; et al. 2012. "Association study of IL10 and IL23R-IL12RB2 in Iranian patients with Behçet's disease". Arthritis & Rheumatism, 64 (8): 2761-2772. https://doi.org/10.1002/art.34437
Xavier, J.M.; Shafiee, N.M.; Ghaderi, F.; Rosa, A.; Abdollahi, B.S.; Nadji, A.; Shahram, F.; Davatchi, F.; Oliveira, S.A.. 2011. "Association of mitochondrial polymorphism m.709GA with Behçet's disease". Annals of the Rheumatic Diseases, 70 (8): 1514-1516. https://doi.org/10.1136/ard.2010.143537
Krug, T.; Manso, H.; Gouveia, L.; Sobral, J.; Xavier, J.M.; Albergaria, I.; Gaspar, G.; et al. 2010. "Kalirin: A novel genetic risk factor for ischemic stroke". Human Genetics, 127 (5): 513-523. https://doi.org/10.1007/s00439-010-0790-y
Xavier, Joana Gonçalves de Gouveia Maia. 2008. "Estudo de linkage e pesquisa de mutações numa família portuguesa com doença de behçet e espondilite anquilosante". Mestrado. http://catalogo.ul.pt/F/?func=item-global&doc_library=ULB01&type=03&doc_number=000579887
